| Literature DB >> 27864861 |
L Woestmann1, J Kvist2, M Saastamoinen1.
Abstract
Flight represents a key trait in most insects, being energetically extremely demanding, yet often necessary for foraging and reproduction. Additionally, dispersal via flight is especially important for species living in fragmented landscapes. Even though, based on life-history theory, a negative relationship may be expected between flight and immunity, a number of previous studies have indicated flight to induce an increased immune response. In this study, we assessed whether induced immunity (i.e. immune gene expression) in response to 15-min forced flight treatment impacts individual survival of bacterial infection in the Glanville fritillary butterfly (Melitaea cinxia). We were able to confirm previous findings of flight-induced immune gene expression, but still observed substantially stronger effects on both gene expression levels and life span due to bacterial infection compared to flight treatment. Even though gene expression levels of some immunity-related genes were elevated due to flight, these individuals did not show increased survival of bacterial infection, indicating that flight-induced immune activation does not completely protect them from the negative effects of bacterial infection. Finally, an interaction between flight and immune treatment indicated a potential trade-off: flight treatment increased immune gene expression in naïve individuals only, whereas in infected individuals no increase in immune gene expression was induced by flight. Our results suggest that the up-regulation of immune genes upon flight is based on a general stress response rather than reflecting an adaptive response to cope with potential infections during flight or in new habitats.Entities:
Keywords: zzm321990Melitaea cinxiazzm321990; gene expression; immune response; insect flight
Mesh:
Year: 2016 PMID: 27864861 PMCID: PMC5347902 DOI: 10.1111/jeb.13007
Source DB: PubMed Journal: J Evol Biol ISSN: 1010-061X Impact factor: 2.411
Relative expression levels and fold increase for the used immune genes divided by the different treatment groups
| Gene | Flight treatment | Immune treatment | Relative expression difference (log2) | Fold increase | SE |
|
|---|---|---|---|---|---|---|
| Lysozyme | Control | PBS | 0.46 | 1.38 | 0.24 | 0.94 |
| AIC = 414.58; | Bacteria | −0.02 | 0.99 | 0.49 | 1.0 | |
| Flight | Naïve | 0.49 | 1.40 | 0.3 | 0.91 | |
| PBS | 0.62 | 1.54 | 0.29 | 0.79 | ||
| Bacteria | 0.14 | 1.10 | 0.31 | 0.99 | ||
| β‐1,3‐glucan recognition protein | Control | PBS | 1.29 | 2.45 | 0.35 | 0.12 |
| AIC = 418.84; | Bacteria | 4.48 | 22.32 | 0.27 |
| |
| Flight | Naïve | 1.46 | 2.75 | 0.3 |
| |
| PBS | 1.67 | 3.18 | 0.25 |
| ||
| Bacteria | 4.71 | 26.17 | 0.44 |
| ||
| proPO | Control | PBS | 0.32 | 1.25 | 0.26 | 0.99 |
| AIC = 419.61; | Bacteria | 1.28 | 2.43 | 0.45 | 0.11 | |
| Flight | Naïve | 0.47 | 1.39 | 0.24 | 0.94 | |
| PBS | 0.1 | 1.07 | 0.29 | 0.99 | ||
| Bacteria | 0.45 | 1.37 | 0.26 | 0.99 | ||
| Serpin | Control | PBS | 0.5 | 1.41 | 0.22 | 0.92 |
| AIC = 421.55; | Bacteria | 1.29 | 2.45 | 0.49 | 0.11 | |
| Flight | Naïve | 0.29 | 1.22 | 0.49 | 0.99 | |
| PBS | 0.9 | 1.87 | 0.12 | 0.47 | ||
| Bacteria | 1.66 | 3.16 | 0.2 |
| ||
| Attacin | Control | PBS | 6.41 | 85.04 | 0.52 |
|
| AIC = 572.59; | Bacteria | 9.08 | 541.19 | 0.73 |
| |
| Flight | Naïve | 2.99 | 7.94 | 0.77 |
| |
| PBS | 4.26 | 19.16 | 0.66 |
| ||
| Bacteria | 8.18 | 290.02 | 0.85 |
| ||
| Pelle | Control | PBS | 1.22 | 2.33 | 0.24 | 0.16 |
| AIC = 423.07; | Bacteria | 4.65 | 25.11 | 0.37 |
| |
| Flight | Naïve | 1.9 | 3.73 | 0.32 |
| |
| PBS | 2.61 | 6.11 | 0.46 |
| ||
| Bacteria | 3.82 | 14.12 | 0.32 |
| ||
| PGRP‐LC | Control | PBS | 0.73 | 1.66 | 0.12 | 0.14 |
| AIC = 312.23.07; | Bacteria | 0.66 | 1.58 | 0.25 | 0.22 | |
| Flight | Naïve | 0.81 | 1.75 | 0.18 | 0.07 | |
| PBS | 0.93 | 1.91 | 0.15 |
| ||
| Bacteria | 0.72 | 1.65 | 0.18 | 0.14 |
Expression levels are calibrated to naïve individuals without flight treatment, and sexes are pooled. Significant effects are highlighted in bold and calculated with Post hoc analysis (Tukey honest significant differences).
Figure 1Immune gene expression in the Glanville fritillary butterfly. Shown are the relative expression levels (log2‐transformed) of the seven tested immune genes of naïve (white), PBS‐injected (blue; wounding with 2 μL PBS) and bacteria‐injected (red; 2 μL of 5‐mg mL−1 Micrococcus luteus in PBS) individuals divided into control (C) and flight (F) treatment groups. Expression levels are calibrated to the naïve individuals that did not experience flight treatment. Sexes are combined, as no sex difference was observed. The P‐values for the effect of flight and immune treatment and their interaction, whenever significant, are presented. The interactions between flight and immune treatment found for attacin and pelle are indicated with asterisks and lines based on the Post hoc test performed.
Figure 2Survival of the adult (a) females and (b) males in days. Solid lines indicate individuals without flight treatment (C), whereas dashed lines indicate those with flight treatment (F) prior to injection. Naïve group is presented in black (n = 17 (C) and n = 19 (F) for females and n = 25 (C) and n = 24 (F) for males) in comparison with the group injected with 2 μL PBS in blue (n = 16 (C) and n = 17 (F) for females and n = 22 (C) and n = 24 (F) for males) and the group injected with 2 μL of a 5‐mg mL−1 Micrococcus luteus solution in PBS in red (n = 18 (C) and n = 19 (F) for females and n = 24 (C) and n = 23 (F) for males). Only bacterial injection resulted in a significant reduction of the life span for both sexes.